SB-509

DB05579InvestigationalSmall molecule

SB-509 is under investigation in multiple clinical trials for the treatment of Diabetic Neuropathy.

Primary indication
Investigated for use/treatment in neuropathy (diabetic).Curator reviewed
Code names
SB-509

What you can answer from here — as of April 02, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of SB-509, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In